CXHL1401953 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-16 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1401956 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-16 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1401952 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-16 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1401954 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-16 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1401951 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-16 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1401955 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-16 | 瑞阳制药有限公司 | Reyoung Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |
CXHL1401752 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-12-17 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-04-15 | view |
CXHL1401751 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-12-17 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-04-15 | view |
CXHL1401750 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-12-17 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-04-15 | view |
CXHL1501939 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-11-10 | 杭州和泽医药科技有限公司 | Zhejiang Heze Pharmaceutical Technology Co Ltd | Certificate Issued | 2016-11-09 | view |
CXHL1501938 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-11-10 | 杭州和泽医药科技有限公司 | Zhejiang Heze Pharmaceutical Technology Co Ltd | Certificate Issued | 2016-11-09 | view |
CXHL1401438 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-10-31 | 杭州华东医药集团新药研究院有限公司 | Hangzhou Huadong MEDICINE Group Pharmaceutical Research Institute Co Ltd | Certificate Issued | 2016-03-25 | view |
CXHL1401437 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-10-31 | 杭州华东医药集团新药研究院有限公司 | Hangzhou Huadong MEDICINE Group Pharmaceutical Research Institute Co Ltd | Certificate Issued | 2016-03-25 | view |
JXHL1100458 | Perampanel Tablets | Perampanel | Tablet | Chemical Drugs | Import Drug Application | 2011-12-28 | 昆泰医药研发(北京)有限公司 | Q Squared Solutions (Beijing) Co Ltd;Eisai Co Ltd | Certificate Issued | 2012-12-28 | view |
JYHB1900891 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs | Supplementary Application | 2019-07-26 | 卫材(中国)药业有限公司 | Eisai China Inc;Kawashima Factory Of Eisai Co Ltd;Eisai Europe Ltd | Certificate Issued | 2019-10-15 | view |
JYHB2001714 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-09-08 | 卫材(中国)药业有限公司 | Eisai China Inc;Kawashima Factory Of Eisai Co Ltd;Eisai Europe Ltd | Filed | 2020-09-18 | view |
JXHL2000089 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-05-11 | 卫材(中国)药业有限公司 | Eisai China Inc;Eisai GmbH | In Review | 2020-05-10 | view |
JXHS2000156 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材(中国)药业有限公司 | Eisai China Inc;Eisai GmbH;Kawashima Factory Of Eisai Co Ltd | Certificate Issued | 2021-07-30 | view |
JXHL1500179 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs | Import Drug Application | 2015-07-23 | 卫材(中国)药业有限公司 | Eisai China Inc;Eisai Europe Ltd | Approval Completed-Pending Certificated | 2017-04-06 | view |
JYHB2001713 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-09-08 | 卫材(中国)药业有限公司 | Eisai China Inc;Kawashima Factory Of Eisai Co Ltd;Eisai Europe Ltd | Filed | 2020-09-18 | view |